About this trial
The QUESAM study aims to translate into French and validate the traduction of 2 screening questionnaires for spondylo-arthritis among people with inflammatory bowel disease.
DETAIL (DETection of Arthritis in Inflammatory boweL diseases) and IBIS-Q (Inflammatory Bowel disease Identification of Spondyloarthritis Questionnaire) questionnaires are built to determine which patients might benefit from a rheumatologic consultation, for a potential rheumatologic inflammatory disease.
The investigators will translate the 2 questionnaire in french thanks to an external translation company, from english to french, then back to english to make sure the translation is correct.
Then, the main question is:
is there a conceptual and semantic equivalence beetween the original english questionnaire and the french-translated one.
Participant will answer the 2 screening questionnaire, one initial time during a consultation, and a second time after 1 month.
Eligibility criteria
Qualifiers
Patient with an inflammatory bowel disease according to gastroenterologist
Disqualifiers
No exclusion criteria
Difficulty for understanding or reading french
Persons covered by articles L1121-5 to L1121-8 of the French Public Health Code
Patients with no social security coverage.
Trial design
Treatments tested in this trial
- Screening questionnaire
Treatment groups
Locations
1Sponsors and collaborators
University Hospital, Grenoble
Lead sponsor
Clinique des Cèdres, Echirolles
Collaborator